Skip to main navigation
Sangamo Therapeutics, Inc
  • About Us
    • Leadership
    • Locations
    • Contact
  • Technology
    • Genomic Medicines
      • Gene Therapy
      • Cell Therapy
      • Genome Editing
      • Genome Regulation
    • Zinc Finger Platform
    • Presentations
    • Publications
  • Pipeline
  • Patients
    • Patient Stories
      • Stories of MPS
      • Stories of Hemophilia
      • Stories of Fabry Disease
      • Stories of Stories of Beta Thalassemia
    • Resources
    • Expanded Access Program
  • Clinical Trials
  • Collaborations
  • Investors + Media
    • Investors + Media
      • Corporate Profile
      • Email Alerts
      • Media Library
    • Stock Information
      • Historic Price Lookup
      • Investment Calculator
      • Institutional Ownership
    • News Releases
    • Events + Presentations
    • Financials + SEC Filings
      • Quarterly Results
      • Analyst Coverage
      • Earnings Estimates
      • Financial Fundamentals
        • Trading Statistics
        • Balance Sheet
        • Income Statement
        • Cash Flow
        • Snapshot
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
  • Careers
    • Sangamo Culture
    • Our Values
    • Job Opportunities
  • About Us
    • Leadership
    • Locations
    • Contact
  • Technology
    • Genomic Medicines
      • Gene Therapy
      • Cell Therapy
      • Genome Editing
      • Genome Regulation
    • Zinc Finger Platform
    • Presentations
    • Publications
  • Pipeline
  • Patients
    • Patient Stories
      • Stories of MPS
      • Stories of Hemophilia
      • Stories of Fabry Disease
      • Stories of Stories of Beta Thalassemia
    • Resources
    • Expanded Access Program
  • Clinical Trials
  • Collaborations
  • Investors + Media
    • Investors + Media
      • Corporate Profile
      • Email Alerts
      • Media Library
    • Stock Information
      • Historic Price Lookup
      • Investment Calculator
      • Institutional Ownership
    • News Releases
    • Events + Presentations
    • Financials + SEC Filings
      • Quarterly Results
      • Analyst Coverage
      • Earnings Estimates
      • Financial Fundamentals
        • Trading Statistics
        • Balance Sheet
        • Income Statement
        • Cash Flow
        • Snapshot
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
  • Careers
    • Sangamo Culture
    • Our Values
    • Job Opportunities

Events

  • Investors + Media
    • Corporate Profile
    • Email Alerts
    • Media Library
  • Stock Information
    • Historic Price Lookup
    • Investment Calculator
    • Institutional Ownership
  • News Releases
  • Events + Presentations
  • Financials + SEC Filings
    • Quarterly Results
    • Analyst Coverage
    • Earnings Estimates
    • Financial Fundamentals
      • Trading Statistics
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Snapshot
  • Corporate Governance
    • Leadership Team
    • Board of Directors
    • Committee Composition

Events

Presentations
Sangamo Corporate Presentation February 2021
February 24, 2021
ASH 2020: Update for the Alta Study, a Phase 1/2 Gene Therapy Trial of Giroctocogene Fitelparvovec (SB-525) in Adults With Severe Hemophilia A
December 7, 2020
Upcoming Events
More events are coming soon.
Past Events
Sangamo R&D Day
Dec 17, 2019 at 8:00 AM EST
Sangamo 3rd Quarter 2019 Teleconference Call
Nov 6, 2019 at 2:00 PM PST
Sangamo 2nd Quarter 2019 Teleconference Call
Aug 7, 2019 at 2:00 PM PDT
Sangamo 1st Quarter 2019 Teleconference Call
May 8, 2019 at 5:00 PM EDT
Sangamo 4th Quarter and Full Year 2018 Teleconference Call
Feb 28, 2019 at 2:00 PM PST

Pagination

  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
footer-logo

© Sangamo Therapeutics

LinkedIn Twitter Facebook
  • Disclaimer
  • Privacy Policy